Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Feb 12, 2014 shooter eric m Director Sell 15,000 320.41 - 321.22
Nov 26, 2013 shooter eric m Director Acquisition (Non Open Market) 8,185 n/a
Nov 26, 2013 shooter eric m Director Disposition (Non Open Market) 8,185 n/a
Feb 12, 2014 shooter eric m Director Acquisition (Non Open Market) 7,000 n/a
Feb 12, 2014 shooter eric m Director Disposition (Non Open Market) 7,000 n/a
Feb 14, 2014 sing george l Director Sell 15,000 324.00
Feb 21, 2014 sing george l Director Sell 15,000 338.00 - 340.00
Nov 26, 2013 sing george l Director Sell 10,000 295.00
May 10, 2013 sing george l Director Sell 5,000 270.00
Nov 18, 2015 sing george l Director Sell 3,000 580.00
Nov 18, 2015 sing george l Director Sell 500 580.00
May 27, 2015 sing george l Director Sell 5,000 515.00
Feb 20, 2015 sing george l Director Sell 15,000 423.12
May 18, 2010 sing george l Director Buy 5,000 28.44
May 18, 2010 sing george l Director Buy 2,500 28.64
Dec 17, 2012 sing george l Director Disposition (Non Open Market) 10,000 n/a
Dec 17, 2012 sing george l Director Acquisition (Non Open Market) 10,000 n/a
Nov 13, 2012 sing george l Director Sell 5,000 148.00
Nov 16, 2012 sing george l Director Sell 5,000 152.00
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Showing 341-360 of 1039 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)